| 4OT5: Crystal Structure Of Btk Kinase Domain Complexed With 4-Tert (3-{8-[4-(4-Methyl-Piperazine-1-Carbonyl)-Phenylamino]-Imid A]Pyrazin-6-Yl}-Phenyl)-Benzamide reference: Structure-Based Drug Design of RN486, a Potent and Selective Bruton's Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis., Lou Y, Han X, Kuglstatter A, Kondru RK, Sweeney ZK, Soth M, McIntosh J, Litman R, Suh J, Kocer B, Davis D, Park J, Frauchiger S, Dewdney N, Zecic H, Taygerly JP, Sarma K, Hong J, Hill RJ, Gabriel T, Goldstein DM, Owens TD, J Med Chem. 2014 Apr 16. PMID: 24712864 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).